Insider Transactions in Q1 2025 at Athira Pharma, Inc. (ATHA)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 02
2025
|
Martin Javier San CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,826
-23.2%
|
$0
$0.56 P/Share
|
|
Jan 02
2025
|
Mark Worthington General Counsel and CCO |
SELL
Open market or private sale
|
Direct |
8,510
-9.23%
|
$0
$0.56 P/Share
|
|
Jan 02
2025
|
Robert Renninger VP of Finance |
SELL
Open market or private sale
|
Direct |
2,881
-3.11%
|
$0
$0.56 P/Share
|
|
Jan 02
2025
|
Kevin Church CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
8,510
-6.11%
|
$0
$0.56 P/Share
|
|
Jan 02
2025
|
Mark James Litton President and CEO |
SELL
Open market or private sale
|
Direct |
25,107
-9.38%
|
$0
$0.56 P/Share
|